Biochemical Markers of Cancer FeaturedShow: Second Opinion
Dr. Emil K. Schandl, MS., Ph.D.
Biomedical Technologies for Early Cancer Detection
The US Centers for Disease Control & Prevention (CDC) reports that cancer is the second leading cause of death in the United States, claiming the lives of more than half a million Americans every year. Dr. Emil K. Schandl joins the show to present a novel diagnostic tool to facilitate early cancer detection, known as The CA Profile. Dr. Schandl emphasizes the key objective of keeping the body’s cells oxygenated, and shares tips for an anti-aging regimen of exercise, detoxification, nutrition and dietary supplementation.
A Clinical Biochemist with a Ph.D. in Molecular Genetics from Florida State University, Dr. Emil K. Schandl, MS., Ph.D., FACB, SC(ASCP), CC(NRCC), LNC, serves as Clinical Laboratory Director (FL, NY, CA, etc.) for American Metabolic Laboratories, Immuno Laboratories, and Metabolic Research in South Florida. He also is an Oncobiologist and Nutrition Consultant practicing in Hollywood, FL.
www.caprofile.net
Dr. Ronald Klatz
2011-03-27
|